Filing Details

Accession Number:
0001209191-21-016470
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-02 18:56:11
Reporting Period:
2021-02-26
Accepted Time:
2021-03-02 18:56:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124140 Exact Sciences Corp EXAS Services-Commercial Physical & Biological Research (8731) 204782291
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1306119 T Kevin Conroy C/o Exact Sciences Corp.
5505 Endeavor Lane
Madison WI 53719
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-26 9,312 $0.00 819,677 No 4 M Direct
Common Stock Disposition 2021-03-01 4,335 $137.44 815,342 No 4 S Direct
Common Stock Disposition 2021-03-01 26,958 $136.79 788,384 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2021-02-26 9,312 $0.00 9,312 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,624 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 26,325 Indirect Held in 401(k) Plan
Common Stock 21,730 Indirect Held in Grantor Retained Annuity Trust
Common Stock 21,730 Indirect Held in Grantor Retained Annuity Trust
Common Stock 21,729 Indirect Held in Grantor Retained Annuity Trust
Footnotes
  1. Represents shares of common stock received upon vesting of a restricted stock unit award.
  2. Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 26, 2021.
  3. The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan, which trading plan was disclosed via Form 8-K filed by Exact Sciences Corporation with the U.S. Securities and Exchange Commission on November 27, 2019.
  4. In addition to the shares of Common Stock reported on this Form 4, which total 879,898 shares, Mr. Conroy also holds, in the aggregate, an additional 1,228,493 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
  5. Each restricted stock unit represents a contingent right to receive one share of common stock.
  6. Represents a restricted stock unit award granted on February 26, 2019 that partially vested on February 26, 2021. The restricted stock units vest in four equal annual installments beginning on February 26, 2020.